Comparison of Second-Phase Insulin Secretion Derived from Standard and Modified Low-Dose Graded Glucose Infusion Tests

Can J Diabetes. 2016 Dec;40(6):529-534. doi: 10.1016/j.jcjd.2016.03.007. Epub 2016 May 27.

Abstract

Objectives: Insulin secretion has 2 phases, first-phase and second-phase insulin secretion (SPIS). The purpose of our study was to validate the SPIS derived from the modified low-dose graded glucose infusion test (MLDGGI) by using the standard SPIS derived from the low-dose graded glucose infusion test (LDGGI).

Methods: Fourteen participants were enrolled. The participants underwent the LDGGI for 200 minutes and MLDGGI for 60 minutes. The LDGGI was administered using the standard Polonsky method, which entails 5 40-minute stages of glucose infusion (1, 4, 8, 6 and 24 mg/kg/min). The slopes of the insulin levels vs. the glucose levels obtained during the test were regarded as SPIS (SPIS-I). Furthermore, deconvolution was performed, and slopes of the insulin secretion rate (ISR) against glucose levels during the test (SPIS-D) were obtained and regarded as the gold standard SPIS. The MLDGGI was administered with 3 20-minute stages of glucose infusion (2, 8 and 24 mg/kg/min) for 20 minutes each. The slopes of the insulin levels vs. the glucose levels obtained during the test were regarded as SPIS (MSPIS-I). In addition, deconvolution was performed, and the slopes of the ISR against glucose levels during the test (MSPIS-D) were obtained.

Results: Significant correlations were observed between SPIS-I and SPIS-D (r=0.843; p<0.001) and between MSPIS and SPIS-D (r=0.786; p<0.001).

Conclusions: SPIS could be determined simply by using the LDGGI without deconvolution. Moreover, MLDGGI was proved to be useful in estimating SPIS easily on the basis of insulin levels.

Keywords: low-dose graded glucose infusion test; modified low-dose graded glucose infusion test; second-phase insulin secretion; seconde phase d'insulinosécretion; test de perfusion de glucose par palier de faible dose; test modifié de perfusion de glucose par palier de faible dose.

Publication types

  • Comparative Study

MeSH terms

  • Adult
  • Aged
  • Biomarkers / analysis
  • Diabetes Mellitus, Type 2 / drug therapy*
  • Diabetes Mellitus, Type 2 / physiopathology
  • Dose-Response Relationship, Drug
  • Female
  • Follow-Up Studies
  • Glucose / administration & dosage*
  • Glucose / chemistry
  • Glucose / pharmacology
  • Glucose Tolerance Test
  • Humans
  • Infusions, Intravenous
  • Insulin / metabolism*
  • Insulin Secretion
  • Male
  • Middle Aged
  • Prognosis

Substances

  • Biomarkers
  • Insulin
  • Glucose